obesity
OBESITY
Obesity is having an excessive amount of body fat in relation to lean body mass that may impair health.
The primary cause is an energy imbalance between calories consumed and expended.
Treatment goals include to lose 5-10% of body weight or 0.5-1 kg (1-2 lb)/week for 6 months and regain of <3 kg in 2 years and sustained reduction of waist circumference of at least 4 cm.
Strategies are aiming for realistic goals and a multidisciplinary approach that is a combination of dietary change, physical activity and behavioral modification.
  1. Cosentino G, Conrad AO, Uwaifo GI. Phentermine and topiramate for the management of obesity: a review. Drug Des Devel Ther. 2011 Apr;7:267-278. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623549/. Accessed 31 Jul 2013. PMID: 23630412
  2. Arterburn D, Hilton L, Li Z, et al. Meta-Analysis: pharmacologic treatment of obesity. Ann Intern Med. 2005 Apr;142(7):532-546. PMID: 15809465
  3. Bray GA. Medical therapy for obesity- current status and future hopes. Med Clin North Am. 2007 Nov;91(6):1225-1253. PMID: 17964918
  4. Lau DC, Douketis JD, Morrison KM, et al; Obesity Canada Clinical Practice Guidelines Expert Panel. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ. 2007 Apr;176(8):S1-13. PMID: 17420481
  5. James WP, Astrup A, Finer N. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet. 2000 Dec;356(9248):2119-2125. PMID: 11191537
  6. Dickerson LM, Carek PJ. Pharmacotherapy for the obese patient. Prim Care. 2009 Jun;36(2):407-415. PMID: 19501251
  7. Mechanick JI, Garber AJ, Handelsman Y, Garvey WT. American Association of Clinical Endocrinologists' position statement on obesity and obesity medicine. Endocr Pract. 2012 Sep;18(5):642-648. PMID: 23047927
  8. Moyer VA; U.S. Preventive Services Task Force. Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012 Sep;157(5):373-378. PMID: 22733087
  9. Padwal R, Li S, Lau D. Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev. 2004;3:CD004094. PMID: 15266516
  10. Shewmake RA, Huntington MK. Nutritional treatment of obesity. Prim Care. 2009 Jun;36(2):357-377. PMID: 19501248
  11. Torgerson JS, Hauptman J, Boldrin MN, et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004 Jan;27(1):155-161. PMID: 14693982
  12. Snow V, Barry P, Fitterman N, Qaseem A, et al; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2005 Apr;142(7):525-531. PMID: 15809464
  13. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004 Jan 10;363(9403):157-163. doi: 10.1016/S0140-6736(03)15268-3. PMID: 14726171
  14. Wood AJ. Obesity. N Engl J Med. 2002 Feb;346(8):591-602. PMID: 11856799
  15. Tsigos C, Hainer V, Basdevant A, et al; Obesity Management Task Force of the European Association of the Study of Obesity. Management of obesity in adults: European clinical practice guidelines. Obes Facts. 2008;1(2):106-116. PMID: 20054170
  16. MedWormhttp://www.medworm.com/rss/index.php/Endocrinology/15/http://www.medworm.com/rss/medicalfeeds/specialities/Endocrinology.xml
  17. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  18. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation website. http://www.idf.org/. Apr 2005.
  19. U.S. Food and Drug Administration. Medication guide: Qsymia. http://www.fda.gov/downloads/Drugs/DrugSafey/UCM312590.pdf. 2012. Accessed 31 Jul 2013.
  20. National Institutes of Health, National Heart, Lung & Blood Institute, North American Association for the Study of Obesity. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf. 01 Oct 2000
  21. Academy of Medicine of Malaysia, Malaysian Association for the Study of Obesity, Malaysian Endocrine and Metabolic Society, and The Ministry of Health, Malaysia. Clinical practice guidelines on the management of obesity. www.moh.gov.my/attachments/3932. 2004
  22. Ministry of Health Malaysia, Academy of Medicine , Malaysian Association for the Study of Obesity, Malaysian Endocrine and Metabolic Society. Management of obesity. http://www.endocrine.my/file_dir/13257576164a1a5d51eb31a.pdf. 2004
  23. Ministry of Health Singapore, Singapore Association for the Survey of Obesity. MOH clinical practice guidelines. Obesity. http://www.moh.gov.sg/content/moh_web/home.html. May 2004
  24. World Health Organization. Obesity and overweight. WHO. http://www.who.int. Accessed 11 Jun 2010.
  25. Inoue S, Zimmet P, Caterson I, et al. The Asia-Pacific perspective: redefining obesity and its treatment. http://www.obesityasiapacific.com/pdf/obesity.pdf. Feb 2000
  26. Institute for Clinical Systems Improvement (ICSI). Prevention and management of obesity (mature adolescents and adults). http://www.icsi.org. Jan 2009. Accessed 10 Jun 2010.
  27. National Institute for Health and Care Excellence. Obesity: guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. NICE. http://www.nice.org.uk/nicemedia/live/11000/30365/30365. Dec 2006. Accessed 11 Jun 2010.
  28. Institute for Clinical Systems Improvement (ICSI). Prevention and management of obesity (mature adolescents and adults). http://www.qualitymeasures.ahrq.gov. Apr 2011.
  29. Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015 Feb;100(2):342-362. doi: 10.1210/jc.2014- 3415 . PMID: 25590212
  30. Jensen MD, Ryan DH, Apovian CM,et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society. Circulation. 2014 Jun;129(25)(Suppl 2):S102-S138. doi: 10.1161/01.cir.0000437739.71477.ee. Accessed 6 Oct 2015. PMID: 24222017
  31. Gonzalez-Campoy JM, St Jeor ST, Castorino K, et al. Clinical practice guidelines for healthy eating for the prevention and treatment of metabolic and endocrine diseases in adults: cosponsored by the American Association of Clinical Endocrinologists/the American College of Endocrinology and the Obesity Society. Endocr Pract. 2013 Sep;19(Suppl 3):1-82. doi: 10.4158/EP13155.GL. Accessed 07 Apr 2014. PMID: 24129260
  32. Guerrero AE, Gonzalez-Santos LE, Caole-Ang IV, et al. 2015 Updated clinical practice guidelines for the management of dyslipidemia in the Philippines. Philippine Society of Endocrinology, Diabetes and Metabolism. http://endo-society.org.ph. 2015. Accessed 03 Aug 2016.
  33. Bray GA, Frühbeck G, Ryan DH, et al. Management of obesity. Lancet. 2016 May 7;387(10031):1947-1956. doi: 10.1016/S0140-6736(16)00271-3. PMID: 26868660
  34. Garvey WT, Mechanick JI, Brett EM, et al; reviewer of the AACE/ACE Obesity Clinical Practice Guidelines. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016 Jul;22(Suppl 3):1-203. doi: 10.4158/EP161365.GL. PMID: 27219496
  35. Gadde KM, Martin CK, Berthoud HR, et al. Obesity: Pathophysiology and management. J Am Coll Cardiol. 2018 Jan 2;71(1):69-84. doi: 10.1016/j.jacc.2017.11.011. PMID: 29301630
  36. Kasama K, Mui W, Lee WJ, et al. IFSO-APC consensus statements 2011. Obes Surg. 2012 May;22(5):677-684. doi: 10.1007/s11695-012-0610-7. PMID: 22367008
  37. Health Promotion Board, Singapore. Obesity. HPB-MOH clinical practice guidelines 1/2016. Ministry of Health Singapore. https://www.moh.gov.sg. 2016.
  38. Durrer Schutz D, Busetto L, Dicker D, et al. European practical and patient-centred guidelines for adult obesity management in primary care. Obes Facts. 2019 Jan;12(1):40-66. doi: 10.1159/000496183. PMID: 30673677
  39. Lim RB. Bariatric procedures for the management of severe obesity. UpToDate. http://www.uptodate.com. Sep 2018.
  40. Perreault L. Obesity in adults: behavioral therapy. UpToDate. http://www.uptodate.com. Oct 2018.
  41. Perreault L. Obesity in adults: drug therapy. UpToDate. http://www.uptodate.com. Feb 2019.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
06 Oct 2018
Supplementation with resistant starch for 12 weeks decreases the inflammatory marker tumour necrosis factor [TNF]-α and heart rate but does not significantly improve glycaemic control and other cardiovascular disease risk factors in prediabetic adults, suggests a study.
4 days ago
Use of the feminizing hormone therapy medroxyprogesterone acetate (MPA) results in minimal side effects, unchanged oestradiol levels and a decline in testosterone in a cohort of transwomen, a study has found.
29 Sep 2019
The duration and degree of overweight in adulthood appear to have lasting influence on breast and colorectal cancer survival, a study has found.
22 Jul 2019
The risk of diabetes mellitus is higher among postmenopausal women who develop primary breast cancer, reports a new study.